ScreenerHero

RDNT RadNet, Inc.

NAS · US · Healthcare · Diagnostics & Research · radnet.com
70.57USD+0.92%Mkt Cap: 5.55B $P/E: —

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its servic…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap5.55B USD
Enterprise Value7.26B USD
Revenue (TTM)2.27B USD
Gross Profit235.49M USD
Net Income (TTM)-18.65M USD
Revenue/Share29.52 USD
Last Price70.57 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)78.87
PEG0.96
EV/EBITDA26.29
EV/Revenue3.20
P/S2.43
P/B5.08
EPS (TTM)-0.27
EPS (Forward)0.89
52W Range
50.8256% of range85.84
52W High85.84 USD
52W Low50.82 USD
Profitability
Gross Margin11.54%
Oper. Margin7.89%
EBITDA Margin12.17%
Profit Margin-0.91%
ROE-1.71%
ROA-0.50%
Growth
Revenue Growth25.00%
Earnings Growth-49.10%
Cash Flow & Leverage
Operating CF298.82M USD
CapEx (TTM)213.25M USD
FCF Margin6.95%
FCF Yield2.84%
Net Debt1.46B USD
Net Debt/EBITDA5.28
Balance Sheet
Debt/Equity1.71
Current Ratio1.48
Quick Ratio1.39
Book Value/Sh13.76 USD
Cash/Share9.23 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:2
Split DateNov 28, 2006
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)94.63 USD
Upside (mean)+34.1%
Target Range79.00 USD – 105.00 USD
79.00+34.1% to mean105.00
# Analysts8
Ownership
Shares Out.78.70M
Float65.76M
Insiders9.96%
Institutions105.42%
Short Interest
Short Ratio14.5d
Short % Float14.54%
Short % Out.12.29%
Shares Short9.67M
Short (prev mo.)9.69M
Technical
SMA 5072.44 (-2.6%)
SMA 20065.48 (+7.8%)
Beta1.40
S&P 52W Chg14.58%
Avg Vol (30d)685.43K
Avg Vol (10d)665.84K
Technical Indicators
RSI (14)46.6
MACD-0.5607
MACD Signal0.1571
MACD Hist.-0.7178
BB Upper77.66 USD
BB Middle72.64 USD
BB Lower67.62 USD
BB Width13.82%
ATR (14)2.611 USD
Vol Ratio (20d)0.91x